PodParley PodParley
GPH 74: HIV/AIDS

EPISODE · Mar 29, 2026 · 46 MIN

GPH 74: HIV/AIDS

from Clinical Deep Dives · host Dr Manaan Kar Ray

HIV/AIDS has shaped modern public health more profoundly than almost any other infectious disease. Since its emergence in the late twentieth century, it has caused millions of deaths, reshaped global health governance, and driven innovation in prevention, treatment, and human rights advocacy.This episode examines:• Global epidemiology and regional variation• Modes of transmission and key populations• Antiretroviral therapy (ART) and treatment as prevention• Pre-exposure prophylaxis (PrEP) and biomedical prevention• Mother-to-child transmission prevention• Stigma, discrimination, and legal barriers• Health system strengthening through HIV programmes• Funding mechanisms and global partnerships• The goal of epidemic control and eliminationHIV/AIDS illustrates the intersection of biology, behaviour, inequality, and political response. The advent of effective antiretroviral therapy transformed HIV from a fatal diagnosis into a chronic, manageable condition. Yet disparities in access persist, particularly in sub-Saharan Africa and among marginalised populations.The episode highlights how sustained investment, community mobilisation, and evidence-based policy have reduced incidence and mortality in many settings - while emphasising the need for continued vigilance and equity.HIV/AIDS is both a scientific and social story - one of resilience, advocacy, and systemic response.────────────────────────────Key Takeaways• HIV/AIDS remains a significant global health issue• Antiretroviral therapy dramatically reduces mortality and transmission• PrEP and prevention of mother-to-child transmission are highly effective• Stigma and legal barriers impede progress• Global funding partnerships have shaped HIV response• Epidemic control requires sustained investment• Equity remains central to elimination efforts This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit drmanaankarray.substack.com/subscribe

NOW PLAYING

GPH 74: HIV/AIDS

0:00 46:52

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Oncology Today with Dr Neil Love Research To Practice Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice. My Take On It with Your Angelic Karma® Your Angelic Karma Here we take a look at how the United States measures alongside other First World Nations. + taking a deep dive into the science -The Report Metagenics Institute Podcast Metagenics Welcome to the Metagenics Institute Podcast where Healthcare Practitioners can hear innovative, cutting-edge information from leading experts from around the world. Join your host, Nathan Rose, to explore the latest evidence in Natural Health, challenge and debunk industry myths and offer practical, tangible, clinical tools which will transform your practice. The Syndicate Blogcast: Startups | Startup Investing | Tech News | Angel Investors | VC | Venture Capital | Private Equity | Crowdfunding | Fundraising Matt Ward - Serial Entrepreneur | Angel Investor | Startup Advisor | Amazon Ecommerce The Syndicate Blogcast show is an extension of The Syndicate podcast, featuring long form articles on the future technology, ecommerce, business and life. The mini-sodes deconstruct high level startup, business and tech issues to help investors and operators better understand and win the market. Recurring topics include: Facebook, Google, Amazon, Apple, Ecommerce, Blockchains, ICOs, Cryptocurrencies, Marketing, Fundraising, Venture Capital, Startup Challenges, Business Development and more. The Blogcast comes in addition to The Syndicate - the place where investors and startups combine to create crazy businesses and even crazier returns. The Syndicate podcast is a deep dive on the angel investors and VCs behind the big name startups. We interview the best and brightest investors, syndicate leads, GPs, limited partners and startup founders to create an original, off the cuff discussion on startup investing.
URL copied to clipboard!